The Issue: Ranitidine injectable is on backorder due to a Health Canada hold on distribution while further quality assurance testing is performed. This is related to the NDMA impurity found in oral ranitidine products earlier this year.
Newsroom
The Issue: Chloroquine 250 mg tablets will expire December 31, 2019 with no alternative supply expected from the single source vendor until 2022.
Anticipated Availability: Resupply date of March 2022.
The Issue: Numerous lots of lidocaine hydrochloride 2% topical jelly X 30 mL sterile tubes have been recalled from Aspen Pharma due to a potential for foreign particle in the tube.
Anticipated Availability: A new lot is expected in January 2020.
Resolution: The shortage of lidocaine 2% with EPINEPHrine 1:100,000 X 20 mL vial is now resolved.
Further information and practice implications.
Effective December 13, 2019
Product Change: NH pharmacy will carry the adult size of Charac®-50 (activated charcoal 50 grams per 225 mL bottle) as regular stock for all locations.
The issue: Dimethyl sulfoxide (DMSO) 50% intravesical aqueous solution is manufactured by Mylan Pharmaceuticals with no other suppliers available.
Anticipated availability: Resupply date is being consistently delayed. Current ETA mid-January 2020.
The issue: The single-source manufacturer of pre-mixed heparin 25,000 units/500 mL D5W bags is on back order with no alternative vendors available.
Anticipated availability: Late February 2020 to early March 2020.